💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Isis Pharmaceuticals, Inc. (ISIS)
« Back to company indexISIS Chatter Timeline
Stock Ticker for ISIS
Most Active Tweeters for ISIS
| User | Tweets |
|---|---|
| @Allstocknews | 4 |
| @FlashAlert_me | 2 |
| @HallowedCrow | 1 |
| @PenthouseBurny | 1 |
| @biggermac2 | 1 |
Recent Tweets for ISIS
 |
@Allstocknews $ISIS New Form SC TO-T/A for Ionis Pharmaceuticals Inc From our Stock News Alerts App 6:09pm |
 |
@biggermac2 RT @FlashAlert_me: $ISIS [15s. delayed] filed SEC form 4: Exec Chairman of the Board CROOKE STANLEY T: Disposed 52,000 of Common Stock at… September 23rd 2020, 6:09pm |
 |
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Exec Chairman of the Board CROOKE STANLEY T: Disposed 52,000 of Common Stoc… https://t.co/n4Q7sQaTBZ September 23rd 2020, 6:09pm |
 |
@PenthouseBurny @Stocktwits Funny story actually... $IONS... formally known as $ISIS... didn’t end well ?? September 23rd 2020, 11:09am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Bank of America Global Healthcare Conference From our Stock News Alerts App September 18th 2020, 7:09am |
 |
@HallowedCrow @AutisticAf Okay, sending five hunnid to $isis… September 17th 2020, 6:09pm |
|
@Allstocknews $ISIS New Form SC TO-T for Ionis Pharmaceuticals Inc From our Stock News Alerts App September 14th 2020, 5:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC TO-T on September 14, 17:11:36 https://t.co/7z6OVIhBCu September 14th 2020, 5:09pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Morgan Stanley 18th Annual Global Healthcare Conference From our Stock News Alerts App September 14th 2020, 7:09am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Wells Fargo 2020 Healthcare Conference From our Stock News Alerts App September 10th 2020, 8:09am |
|
@Allstocknews $ISIS Ionis to present at upcoming virtual investor conferences From our Stock News Alerts App September 3rd 2020, 7:09am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Finance & CFO HOUGEN ELIZABETH L: Acquired 121 of Common Stock at pric… https://t.co/4UFKww4ylR September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP & General Counsel O'NEIL PATRICK R.: Acquired 169 of Common Stock at pr… https://t.co/nIRdrM0wCV September 2nd 2020, 7:09pm |
|
@Allstocknews $ISIS New Form 4 for Ionis Pharmaceuticals Inc From our Stock News Alerts App September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Development Geary Richard S: Acquired 1 of Common Stock at price $44.4… https://t.co/JSB1LQhza3 September 2nd 2020, 7:09pm |
|
@Allstocknews $ISIS New England Journal of Medicine publishes study results evaluating Ionis antisense therapy in treatment From our Stock News Alerts App September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Executive Officer Monia Brett P: Disposed 314 of Common Stock at pric… https://t.co/KY1DvGpka8 September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Scientific Officer BENNETT C FRANK: Acquired 112 of Common Stock at p… https://t.co/qAwAcWCBUV September 2nd 2020, 7:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Research Swayze Eric: Acquired 1 of Common Stock at price $44.45 on 20… https://t.co/018RIz1BB9 September 2nd 2020, 6:09pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC TO-C on September 01, 16:18:59 https://t.co/v68Et1CZG4 September 1st 2020, 4:09pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Cardiovascular Franchise Webcast From our Stock News Alerts App September 1st 2020, 10:09am |
|
@Allstocknews $ISIS New Form SC TO-C for Ionis Pharmaceuticals Inc From our Stock News Alerts App August 31st 2020, 5:08pm |
 |
@Singlemalt_18 @ByJonGardner They should at least change their ticker back to $ISIS August 31st 2020, 1:08pm |
|
@Allstocknews $ISIS New Form SC 13D/A for Ionis Pharmaceuticals Inc From our Stock News Alerts App August 31st 2020, 7:08am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC 13D/A on August 31, 07:12:29 https://t.co/kT8yw7ip4E August 31st 2020, 7:08am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form SC TO-C on August 31, 07:07:59 https://t.co/V6X3i6M0ea August 31st 2020, 7:08am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on August 31, 07:05:04: Item1.01: Entry into a Material Definitive Agreement https://t.co/i924LqTzul August 31st 2020, 7:08am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics From our Stock News Alerts App August 31st 2020, 6:08am |
|
@Allstocknews $ISIS Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 From our Stock News Alerts App August 29th 2020, 4:08am |
|
@Allstocknews $ISIS Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 From our Stock News Alerts App August 29th 2020, 3:08am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals to hold cardio-renal franchise webcast From our Stock News Alerts App August 26th 2020, 7:08am |
|
@Allstocknews $ISIS Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress From our Stock News Alerts App August 24th 2020, 7:08am |
|
@Allstocknews $ISIS Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC From our Stock News Alerts App August 18th 2020, 7:08am |
|
@Allstocknews $ISIS New Form S-8 for Ionis Pharmaceuticals Inc From our Stock News Alerts App August 10th 2020, 6:08am |
|
@Allstocknews $ISIS New Form S-3ASR for Ionis Pharmaceuticals Inc From our Stock News Alerts App August 10th 2020, 6:08am |
|
@Allstocknews $ISIS New Form 10-Q for Ionis Pharmaceuticals Inc From our Stock News Alerts App August 5th 2020, 5:08pm |
|
@Allstocknews $ISIS New Form 8-K for Ionis Pharmaceuticals Inc From our Stock News Alerts App August 5th 2020, 11:08am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on August 05, 11:15:39: Item2.02: Results of Operations & Financial Condition https://t.co/rapaF3vvn9 August 5th 2020, 11:08am |
|
@Allstocknews $ISIS Ionis reports second quarter 2020 financial results and recent business achievements From our Stock News Alerts App August 5th 2020, 7:08am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Second Quarter 2020 Earnings Webcast From our Stock News Alerts App August 4th 2020, 12:08pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals to hold second quarter 2020 financial results webcast From our Stock News Alerts App July 22nd 2020, 7:07am |
 |
@bogusNewsViews @mashednmangled @JohnjoL20 Where's $ISIS or the #Taliban when you need them #RPG! July 15th 2020, 9:07pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Director Hayden Michael R: Converted securities 1,778 of Common Stock at pr… https://t.co/pZb6fyLF6i July 6th 2020, 6:07pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Director HERMAN JOAN E: Converted securities 1,778 of Common Stock at price… https://t.co/a6e4c3mqEw July 6th 2020, 5:07pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Director LOSCALZO JOSEPH: Converted securities 4,000 of Common Stock at ave… https://t.co/Z7BxgbJDUS July 6th 2020, 5:07pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Director PARSHALL B LYNNE: Converted securities 2,667 of Common Stock at av… https://t.co/B2cXQjCDB8 July 6th 2020, 5:07pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Director Castleman Breaux: Disposed 10,000 of Common Stock at price $60 and… https://t.co/omy8KtTOCU June 29th 2020, 9:06pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Chief Scientific Officer BENNETT C FRANK: Disposed 15,000 of Common St… https://t.co/Dz3NzMcklp June 29th 2020, 9:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
